อ้างอิง ของ เนื้องอกมดลูก

  1. ↑ uterine leiomyoma ใน พจนานุกรมศัพท์การแพทย์ดอร์แลนด์
  2. 1 2 Neiger R, Sonek JD, Croom CS, Ventolini G (2006). "Pregnancy-related changes in the size of uterine leiomyomas". The Journal of reproductive medicine. 51 (9): 671–674. PMID 17039693.CS1 maint: Multiple names: authors list (link)
  3. 1 2 3 Wallach EE, Vlahos NF (August 2004). "Uterine myomas: an overview of development, clinical features, and management". Obstet Gynecol. 104 (2): 393–406. doi:10.1097/01.AOG.0000136079.62513.39. PMID 15292018.
  4. ↑ "Benign Uterine Fibroid Tumors (What to Know)". Women's Health. about.com.
  5. 1 2 3 4 5 American Society of Reproductive Medicine Patient Booklet: Uterine Fibroids, 2003
  6. ↑ Segars, J. H.; Parrott, E. C.; Nagel, J. D.; Guo, X. C.; Gao, X.; Birnbaum, L. S.; Pinn, V. W.; Dixon, D. (2014). "Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations". Human Reproduction Update. 20 (3): 309–333. doi:10.1093/humupd/dmt058. ISSN 1355-4786.
  7. ↑ Segars JH, Parrott EC, Nagel JD, Guo XC, Gao X, Birnbaum LS, Pinn VW, Dixon D (2014). "Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations". Hum. Reprod. Update. 20 (3): 309–33. doi:10.1093/humupd/dmt058. PMID 24401287.CS1 maint: Multiple names: authors list (link)
  8. ↑ Garg K, Tickoo SK, Soslow RA, Reuter VE (2011). "Morphologic Features of Uterine Leiomyomas Associated with Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome". The American Journal of Surgical Pathology. 35 (8): 1235–1237. doi:10.1097/PAS.0b013e318223ca01. PMID 21753700.CS1 maint: Multiple names: authors list (link)
  9. ↑ Cucinella G, Granese R, Calagna G, Somigliana E, Perino A (2011). "Parasitic myomas after laparoscopic surgery: An emerging complication in the use of morcellator? Description of four cases". Fertility and Sterility. 96 (2): e90–e96. doi:10.1016/j.fertnstert.2011.05.095. PMID 21719004.CS1 maint: Multiple names: authors list (link)
  10. ↑ Nezhat C, Kho K (2010). "Iatrogenic Myomas: New Class of Myomas?". Journal of Minimally Invasive Gynecology. 17 (5): 544–550. doi:10.1016/j.jmig.2010.04.004. PMID 20580324.
  11. ↑ Kumar_2008Kumar S, Sharma JB, Verma D, Gupta P, Roy KK, Malhotra N (2008). "Disseminated peritoneal leiomyomatosis: An unusual complication of laparoscopic myomectomy". Archives of Gynecology and Obstetrics. 278 (1): 93–95. doi:10.1007/s00404-007-0536-9. PMID 18193441.CS1 maint: Multiple names: authors list (link)
  12. ↑ Galvin SD, Wademan B, Chu J, Bunton RW (2010). "Benign Metastasizing Leiomyoma: A Rare Metastatic Lesion in the Right Ventricle". The Annals of Thoracic Surgery. 89 (1): 279–281. doi:10.1016/j.athoracsur.2009.06.050. PMID 20103256.CS1 maint: Multiple names: authors list (link)
  13. ↑ Mikami I, Yamamoto M, Nishimura H, Koizumi K, Gomibuchi M, Tanaka S (1998). "Multiple lungs tumors found 17 years after hysterectomy--a case of benign metastasizing leiomyoma". The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi. 46 (7): 634–638. doi:10.1007/BF03217793. PMID 9750447.CS1 maint: Multiple names: authors list (link)
  14. 1 2 Fletcher's Diagnostic Histopathology of Tumors (3rd ed.). pp. 692–4.
  15. ↑ Mäkinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M, Aavikko M, Katainen R, Virolainen E, Böhling T, Koski TA, Launonen V, Sjöberg J, Taipale J, Vahteristo P, Aaltonen LA (2011). "MED12, the Mediator Complex Subunit 12 Gene, is Mutated at High Frequency in Uterine Leiomyomas". Science. 334 (6053): 252–255. doi:10.1126/science.1208930. PMID 21868628.CS1 maint: Multiple names: authors list (link)
  16. ↑ Okolo S (2008). "Incidence, aetiology and epidemiology of uterine fibroids". Best practice & research. Clinical obstetrics & gynaecology. 22 (4): 571–588. doi:10.1016/j.bpobgyn.2008.04.002. PMID 18534913.
  17. ↑ Cesen-Cummings K, Houston KD, Copland JA, Moorman VJ, Walker CL, Davis BJ (2003). "Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling". Journal of the Society for Gynecologic Investigation. 10 (1): 11–20. doi:10.1016/S1071-5576(02)00191-0. PMID 12517588.CS1 maint: Multiple names: authors list (link)
  18. ↑ Rein MS (2000). "Advances in uterine leiomyoma research: the progesterone hypothesis". Environmental health perspectives. 108 Suppl 5: 791–3. PMID 11035984.
  19. ↑ Maruo T, Ohara N, Wang J, Matsuo H (2004). "Sex steroidal regulation of uterine leiomyoma growth and apoptosis". Human reproduction update. 10 (3): 207–220. doi:10.1093/humupd/dmh019. PMID 15140868.CS1 maint: Multiple names: authors list (link)
  20. ↑ Wei T, Geiser AG, Qian HR, Su C, Helvering LM, Kulkarini NH, Shou J, N'Cho M, Bryant HU, Onyia JE (2007). "DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids". BMC Women's Health. 7: 5. doi:10.1186/1472-6874-7-5. PMC 1852551. PMID 17407572.CS1 maint: Multiple names: authors list (link)
  21. 1 2 Yen-Ping Ho J, Man WC, Wen Y, Polan ML, Shih-Chu Ho E, Chen B (June 2009). "Transforming growth interacting factor expression in leiomyoma compared with myometrium". Fertil. Steril. 94 (3): 1078–83. doi:10.1016/j.fertnstert.2009.05.001. PMC 2888713. PMID 19524896.CS1 maint: Multiple names: authors list (link)
  22. ↑ Strissel PL, Swiatek J, Oppelt P, Renner SP, Beckmann MW, Strick R (2007). "Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients". The Journal of Steroid Biochemistry and Molecular Biology. 107 (1–2): 42–47. doi:10.1016/j.jsbmb.2007.02.005. PMID 17646097.CS1 maint: Multiple names: authors list (link)
  23. ↑ Massart F, Becherini L, Marini F, Noci I, Piciocchi L, Del Monte F, Masi L, Falchetti A, Tanini A, Scarselli G, Brandi L (2003). "Analysis of estrogen receptor (ERalpha and ERbeta) and progesterone receptor (PR) polymorphisms in uterine leiomyomas". Medical science monitor : international medical journal of experimental and clinical research. 9 (1): BR25–BR30. PMID 12552233.CS1 maint: Multiple names: authors list (link)
  24. ↑ Fischer C, Juhasz-Boess I, Lattrich C, Ortmann O, Treeck O (2010). "Estrogen receptor β gene polymorphisms and susceptibility to uterine fibroids". Gynecological Endocrinology. 26 (1): 4. doi:10.3109/09513590903159573. PMID 19639498.CS1 maint: Multiple names: authors list (link)
  25. ↑ Al-Hendy A, Salama SA (2006). "Ethnic distribution of estrogen receptor-α polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans". Fertility and Sterility. 86 (3): 686. doi:10.1016/j.fertnstert.2006.01.052. PMID 16860797.
  26. ↑ Nam DH, Ramachandran S, Song DK, Kwon KY, Jeon DS, Shin SJ, Kwon SH, Cha SD, Bae I, Cho CH (2007). "Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone". Molecular Human Reproduction. 13 (11): 829–836. doi:10.1093/molehr/gam071. PMID 17893092.CS1 maint: Multiple names: authors list (link)
  27. ↑ Zhang CH, Wen ZQ, Li JF, Li CZ, Shi M, Yang GW, Lan SM, Zhu Y, Wang F, Zhang YJ, Wang YY, Zhang H (2008). "Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells". Chinese medical journal. 121 (2): 166–171. PMID 18272045.CS1 maint: Multiple names: authors list (link)
  28. ↑ Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R (2005). "A Prospective Study of Hypertension and Risk of Uterine Leiomyomata". American Journal of Epidemiology. 161 (7): 628. doi:10.1093/aje/kwi072. PMID 15781952.CS1 maint: Multiple names: authors list (link)
  29. ↑ Isobe A, Takeda T, Sakata M, Miyake A, Yamamoto T, Minekawa R, Nishimoto F, Oskamoto Y, Walker CL, Kimura T (2007). "Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation". Human Reproduction. 23 (2): 440–446. doi:10.1093/humrep/dem247. PMID 17993476.CS1 maint: Multiple names: authors list (link)
  30. ↑ Shozu M, Murakami K, Inoue M (2004). "Aromatase and Leiomyoma of the Uterus". Seminars in Reproductive Medicine. 22 (1): 51. doi:10.1055/s-2004-823027. PMID 15083381.CS1 maint: Multiple names: authors list (link)
  31. ↑ Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Zhou J, Sebastian S (2001). "Role of aromatase in endometrial disease". The Journal of Steroid Biochemistry and Molecular Biology. 79 (1–5): 19–25. doi:10.1016/S0960-0760(01)00134-0. PMID 11850203.CS1 maint: Multiple names: authors list (link)
  32. ↑ Ishikawa H, Reierstad S, Demura M, Rademaker AW, Kasai T, Inoue M, Usui H, Shozu M, Bulun SE (2009). "High Aromatase Expression in Uterine Leiomyoma Tissues of African-American Women". Journal of Clinical Endocrinology & Metabolism. 94 (5): 1752–1756. doi:10.1210/jc.2008-2327. PMC 2684481. PMID 19240151.CS1 maint: Multiple names: authors list (link)
  33. ↑ Hodge JC, Morton CC (2007). "Genetic heterogeneity among uterine leiomyomata: insights into malignant progression". Human Molecular Genetics. 16 Spec No 1: R7–13. doi:10.1093/hmg/ddm043. PMID 17613550.
  34. ↑ Payson M, Malik M, Siti-Nur Morris S, Segars JH, Chason R, Catherino WH (2009). "Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development". Fertil Steril. 92 (2): 748–55. doi:10.1016/j.fertnstert.2008.06.030. PMID 18692824.CS1 maint: Multiple names: authors list (link)
  35. ↑ Nierth-Simpson EN, Martin MM, Chiang TC, Melnik LI, Rhodes LV, Muir SE, Burow ME, McLachlan JA (2009). "Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation". Endocrinology. 150 (5): 2436–2445. doi:10.1210/en.2008-0224. PMC 2671893. PMID 19179429.CS1 maint: Multiple names: authors list (link)
  36. 1 2 Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ, Rogers PA (2003). "Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium". Molecular human reproduction. 9 (9): 541–549. doi:10.1093/molehr/gag066. PMID 12900513.CS1 maint: Multiple names: authors list (link)
  37. ↑ Goto A, Takeuchi S, Sugimura K, Maruo T (2002). "Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus". Int. J. Gynecol. Cancer. 12 (4): 354–61. doi:10.1046/j.1525-1438.2002.01086.x. PMID 12144683.CS1 maint: Multiple names: authors list (link)
  38. ↑ "Fibroids". NHS Choices. U.K. National Health Service.
  39. ↑ Tan N, McClure TD, Tarnay C, Johnson MT, Lu DS, Raman SS (2014). "Women seeking second opinion for symptomatic uterine leiomyoma: Role of comprehensive fibroid center". Journal of Therapeutic Ultrasound. 2: 3. doi:10.1186/2050-5736-2-3.CS1 maint: Multiple names: authors list (link)
  40. ↑ Zapata LB, Whiteman MK, Tepper NK, Jamieson DJ, Marchbanks PA, Curtis KM (2010). "Intrauterine device use among women with uterine fibroids: a systematic review☆". Contraception. 82 (1): 41–55. doi:10.1016/j.contraception.2010.02.011. PMID 20682142.CS1 maint: Multiple names: authors list (link)
  41. ↑ Jindabanjerd K, Taneepanichskul S (2006). "The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women". Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 89 Suppl 4: S147–51. PMID 17726816.
  42. 1 2 3 4 5 6 Sankaran S, Manyonda IT (2008). "Medical management of fibroids" (PDF). Best Pract Res Clin Obstet Gynaecol. 22 (4): 655–76. doi:10.1016/j.bpobgyn.2008.03.001. PMID 18468953.
  43. ↑ Kailasam C, Cahill D (2008). "Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system". Patient preference and adherence. 2: 293–302. PMC 2770406. PMID 19920976.
  44. ↑ Sayyah-Melli M, Tehrani-Gadim S, Dastranj-Tabrizi A, Gatrehsamani F, Morteza G, Ouladesahebmadarek E, Farzadi L, Kazemi-Shishvan M (2009). "Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes". Saudi medical journal. 30 (8): 1024–33. PMID 19668882.CS1 maint: Multiple names: authors list (link)
  45. 1 2 Nieman LK, Blocker W, Nansel T, Mahoney S, Reynolds J, Blithe D, Wesley R, Armstrong A (2011). "Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: A randomized, double-blind, placebo-controlled, phase IIb study". Fertility and Sterility. 95 (2): 767–772.e1–772. doi:10.1016/j.fertnstert.2010.09.059. PMID 21055739.CS1 maint: Multiple names: authors list (link)
  46. ↑ Levens ED, Potlog-Nahari C, Armstrong AY, Wesley R, Premkumar A, Blithe DL, Blocker W, Nieman LK (2008). "CDB-2914 for Uterine Leiomyomata Treatment". Obstetrics & Gynecology. 111 (5): 1129–1136. doi:10.1097/AOG.0b013e3181705d0e. PMC 2742990. PMID 18448745.CS1 maint: Multiple names: authors list (link)
  47. ↑ Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, Ugocsai G, Mara M, Jilla MP, Bestel E, Terrill P, Osterloh I, Loumaye E (2012). "Ulipristal acetate versus placebo for fibroid treatment before surgery". N. Engl. J. Med. 366 (5): 409–20. doi:10.1056/NEJMoa1103182. PMID 22296075.CS1 maint: Multiple names: authors list (link)
  48. ↑ Tristan M, Orozco LJ, Steed A, Ramírez-Morera A, Stone P (2012). Orozco, Leonardo J, ed. "Cochrane Database of Systematic Reviews". Cochrane database of systematic reviews (Online). 8: CD007687. doi:10.1002/14651858.CD007687.pub2. PMID 22895965. |chapter= ignored (help)CS1 maint: Multiple names: authors list (link)
  49. ↑ Engman M, Granberg S, Williams AR, Meng CX, Lalitkumar PG, Gemzell-Danielsson K (August 2009). "Mifepristone for Treatment of Uterine Leiomyoma. A Prospective Randomized Placebo Controlled Trial". Human Reproduction. 24 (8): 1870–9. doi:10.1093/humrep/dep100. PMID 19389793.CS1 maint: Multiple names: authors list (link)
  50. ↑ Malartic C, Morel O, Akerman G, Tulpin L, Desfeux P, Barranger E (2008). "La mifépristone dans la prise en charge des fibromes utérins". Gynécologie Obstétrique & Fertilité. 36 (6): 668–74. doi:10.1016/j.gyobfe.2008.01.017. PMID 18539512.CS1 maint: Multiple names: authors list (link)
  51. ↑ Wilkens J, Williams AR, Chwalisz K, Han C, Cameron IT, Critchley HO (2009). "Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN". Human reproduction (Oxford, England). 24 (5): 1036–44. doi:10.1093/humrep/den494. PMID 19176543.CS1 maint: Multiple names: authors list (link)
  52. ↑ "The Embolisation Process". FEmISA: Fibroid Embolisation: Information, Support, Advice.
  53. ↑ Hirst A, Dutton S, Wu O, Briggs A, Edwards C, Waldenmaier L, Maresh M, Nicholson A, McPherson K (2008). "A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study". Health technology assessment (Winchester, England). 12 (5): 1–248, iii. PMID 18331704.CS1 maint: Multiple names: authors list (link)
  54. ↑ Liu WM, Ng HT, Wu YC, Yen YK, Yuan CC (2001). "Laparoscopic bipolar coagulation of uterine vessels: a new method for treating symptomatic fibroids". Fertility and Sterility. 75 (2): 417–22. doi:10.1016/S0015-0282(00)01724-6. PMID 11172850.CS1 maint: Multiple names: authors list (link)
  55. ↑ Kim HS, Kim JW, Kim MK, Chung HH, Lee TS, Jeon YT, Kim YB, Jeon HW, Yun YH, Park NH, Song YS, Kang SB (2009). "A randomized prospective trial of the postoperative quality of life between laparoscopic uterine artery ligation and laparoscopy-assisted vaginal hysterectomy for the treatment of symptomatic uterine fibroids: clinical trial design". Trials. 10: 8. doi:10.1186/1745-6215-10-8. PMC 2645389. PMID 19178748.CS1 maint: Multiple names: authors list (link)
  56. ↑ Akinola OI, Fabamwo AO, Ottun AT, Akinniyi OA (2005). "Uterine artery ligation for management of uterine fibroids". International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 91 (2): 137–40. doi:10.1016/j.ijgo.2005.07.012. PMID 16168993.CS1 maint: Multiple names: authors list (link)
  57. ↑ Hald K, Noreng HJ, Istre O, Kløw NE (2009). "Uterine Artery Embolization versus Laparoscopic Occlusion of Uterine Arteries for Leiomyomas: Long-term Results of a Randomized Comparative Trial". Journal of Vascular and Interventional Radiology. 20 (10): 1303. doi:10.1016/j.jvir.2009.07.022. PMID 19713130.CS1 maint: Multiple names: authors list (link)
  58. ↑ Beck, Melinda (2010-01-20). "A New Treatment to Help Women Avoid Hysterectomy". The Wall Street Journal.
  59. ↑ Metwally M, Cheong YC, Horne AW (2012). Metwally, Mostafa, ed. "Cochrane Database of Systematic Reviews". Cochrane database of systematic reviews (Online). 11: CD003857. doi:10.1002/14651858.CD003857.pub3. PMID 23152222. |chapter= ignored (help)CS1 maint: Multiple names: authors list (link)
  60. ↑ Agdi M, Tulandi T (August 2008). "Endoscopic management of uterine fibroids". Best Pract Res Clin Obstet Gynaecol. 22 (4): 707–16. doi:10.1016/j.bpobgyn.2008.01.011. PMID 18325839.
  61. ↑ "FDA Approves New Device to Treat Uterine Fibroids" (Press release). FDA. 2004-10-22. สืบค้นเมื่อ 2008-05-26.
  62. ↑ Shen SH, Fennessy F, McDannold N, Jolesz F, Tempany C (April 2009). "Image-guided thermal therapy of uterine fibroids". Seminars in ultrasound, CT, and MR. 30 (2): 91–104. doi:10.1053/j.sult.2008.12.002. PMC 2768544. PMID 19358440.CS1 maint: Multiple names: authors list (link)
  63. ↑ Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B, Gastout B, Hesley G, Kim HS, Hengst S, Gedroyc WM, Gedroye WM (January 2006). "Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids". Fertil. Steril. 85 (1): 22–9. doi:10.1016/j.fertnstert.2005.04.072. PMID 16412721.CS1 maint: Multiple names: authors list (link)
  64. ↑ Kurashvili, J.; และคณะ (2010). "MRgFUS Treatment for Uterine Myomas: Safety, Effectiveness and Pathogenesis". MR-guided Focused Ultrasound 2010, 2nd International Symposium.CS1 maint: Explicit use of et al. (link)
  65. ↑ O'Sullivan AK, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC (January 2009). "Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids". Int J Technol Assess Health Care. 25 (1): 14–25. doi:10.1017/S0266462309090035. PMC 2811401. PMID 19126247.CS1 maint: Multiple names: authors list (link)
  66. ↑ Zowall H, Cairns JA, Brewer C, Lamping DL, Gedroyc WM, Regan L (April 2008). "Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids". BJOG. 115 (5): 653–62. doi:10.1111/j.1471-0528.2007.01657.x. PMC 2344162. PMID 18333948.CS1 maint: Multiple names: authors list (link)
  67. ↑ Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V; และคณะ (Dec 15, 2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMID 23245607.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
  68. 1 2 แม่แบบ:MerckManual
  69. ↑ Eggert SL, Huyck KL, Somasundaram P, Kavalla R, Stewart EA, Lu AT, Painter JN, Montgomery GW, Medland SE, Nyholt DR, Treloar SA, Zondervan KT, Heath AC, Madden PA, Rose L, Buring JE, Ridker PM, Chasman DI, Martin NG, Cantor RM, Morton CC (October 2012). "Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata". Am. J. Hum. Genet. 91 (4): 621–8. doi:10.1016/j.ajhg.2012.08.009. PMC 3484658. PMID 23040493.CS1 maint: Multiple names: authors list (link)
  70. ↑ Tolvanen J, Uimari O, Ryynänen M, Aaltonen LA, Vahteristo P (2012). "Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening". Human Reproduction. 27 (6): 1865–9. doi:10.1093/humrep/des105. PMID 22473397.CS1 maint: Multiple names: authors list (link)
  71. ↑ Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O; และคณะ (2003). "Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America". Am J Hum Genet. 73 (1): 95–106. doi:10.1086/376435. PMC 1180594. PMID 12772087.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
  72. ↑ http://rarediseases.info.nih.gov/GARD/Condition/10160/Reed_syndrome.aspx
  73. ↑ "Helping Black Women Recognize, Treat Fibroids". NPR. สืบค้นเมื่อ 30 March 2011.
  74. ↑ "African American Women and Fibroids". Philadelphia Black Women's Health Project. สืบค้นเมื่อ 30 March 2011.
  75. ↑ Wise LA, Palmer JR, Stewart EA, Rosenberg L (March 2005). "Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study". Obstet Gynecol. 105 (3): 563–8. doi:10.1097/01.AOG.0000154161.03418.e3. PMC 1847590. PMID 15738025.CS1 maint: Multiple names: authors list (link)
  76. ↑ "Minority Women's Health". Women's Health.gov.
  77. 1 2 3 "Black Women and High Prevalence of Fibroids". Fibroid Treatment Collective. November 29, 2010. สืบค้นเมื่อ 30 March 2011.
  78. ↑ Wise LA, Radin RG, Palmer JR, Kumanyika SK, Rosenberg L (2010). "A prospective study of dairy intake and risk of uterine leiomyomata". Am. J. Epidemiol. 171 (2): 221–32. doi:10.1093/aje/kwp355. PMC 2800240. PMID 19955473. Lay summary – Science Daily.CS1 maint: Multiple names: authors list (link)
  79. ↑ Wise LA, Palmer JR, Reich D, Cozier YC, Rosenberg L (March 2012). "Hair relaxer use and risk of uterine leiomyomata in African-American women". Am. J. Epidemiol. 175 (5): 432–40. doi:10.1093/aje/kwr351. PMC 3282879. PMID 22234483.CS1 maint: Multiple names: authors list (link)
  80. ↑ http://officeofbudget.od.nih.gov/pdfs/FY11/Approp.%20History%20by%20IC%20(FINAL).pdf
  81. ↑ Bäcklin BM, Eriksson L, Olovsson M (March 2003). "Histology of uterine leiomyoma and occurrence in relation to reproductive activity in the Baltic gray seal (Halichoerus grypus)". Vet. Pathol. 40 (2): 175–80. doi:10.1354/vp.40-2-175. PMID 12637757.CS1 maint: Multiple names: authors list (link)

แหล่งที่มา

WikiPedia: เนื้องอกมดลูก http://womenshealth.about.com/cs/fibroidtumors/a/f... http://www.diseasesdatabase.com/ddb4806.htm http://linkinghub.elsevier.com/retrieve/pii/S0015-... http://linkinghub.elsevier.com/retrieve/pii/S1521-... http://www.emedicine.com/radio/topic777.htm http://www.fibroids.com/news-blog/2010/11/black-wo... http://www.icd9data.com/getICD9Code.ashx?icd9=218.... http://www.mercksource.com/pp/us/cns/cns_hl_dorlan... http://vet.sagepub.com/content/40/2/175.full http://www.sciencedaily.com/releases/2009/12/09120...